272 related articles for article (PubMed ID: 31519967)
1. Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information.
Ettrich TJ; Schwerdel D; Dolnik A; Beuter F; Blätte TJ; Schmidt SA; Stanescu-Siegmund N; Steinacker J; Marienfeld R; Kleger A; Bullinger L; Seufferlein T; Berger AW
Sci Rep; 2019 Sep; 9(1):13261. PubMed ID: 31519967
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice.
Kim KH; Yi HS; Lee H; Bae GE; Yeo MK
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108676
[TBL] [Abstract][Full Text] [Related]
3. Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma.
Gu X; Wang C; Deng H; Qing C; Liu R; Liu S; Xue X
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):475-484. PubMed ID: 32369104
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With
Lapin M; Huang HJ; Chagani S; Javle M; Shroff RT; Pant S; Gouda MA; Raina A; Madwani K; Holley VR; Call SG; Dustin DJ; Lanman RB; Meric-Bernstam F; Raymond VM; Kwong LN; Janku F
JCO Precis Oncol; 2022 Feb; 6():e2100197. PubMed ID: 35171660
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R
J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring.
Choi WJ; Ivanics T; Gravely A; Gallinger S; Sapisochin G; O'Kane GM
Ann Surg Oncol; 2023 Jun; 30(6):3849-3863. PubMed ID: 36808320
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
[TBL] [Abstract][Full Text] [Related]
8. Circulating Biomarkers for Cholangiocarcinoma.
Loosen SH; Vucur M; Trautwein C; Roderburg C; Luedde T
Dig Dis; 2018; 36(4):281-288. PubMed ID: 29807369
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival.
Baumgartner JM; Raymond VM; Lanman RB; Tran L; Kelly KJ; Lowy AM; Kurzrock R
Ann Surg Oncol; 2018 Aug; 25(8):2400-2408. PubMed ID: 29948422
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangiocarcinoma Harboring FGFR2 Alterations.
Varghese AM; Patel J; Janjigian YY; Meng F; Selcuklu SD; Iyer G; Houck-Loomis B; Harding JJ; O'Reilly EM; Abou-Alfa GK; Lowery MA; Berger MF
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250419
[TBL] [Abstract][Full Text] [Related]
11. Methods for Measuring ctDNA in Lymphomas.
Rossi D; Condoluci A; Spina V; Gaidano G
Methods Mol Biol; 2019; 1881():253-265. PubMed ID: 30350211
[TBL] [Abstract][Full Text] [Related]
12. Assessment of ctDNA in CSF may be a more rapid means of assessing surgical outcomes than plasma ctDNA in glioblastoma.
Li JH; He ZQ; Lin FH; Chen ZH; Yang SY; Duan H; Jiang XB; Al-Nahari F; Zhang XH; Wang JH; Zhang GH; Zhang ZF; Li C; Mou YG
Mol Cell Probes; 2019 Aug; 46():101411. PubMed ID: 31173881
[TBL] [Abstract][Full Text] [Related]
13. Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
Chae YK; Davis AA; Agte S; Pan A; Simon NI; Iams WT; Cruz MR; Tamragouri K; Rhee K; Mohindra N; Villaflor V; Park W; Lopes G; Giles FJ
Oncologist; 2019 Jun; 24(6):820-828. PubMed ID: 30867242
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring.
Wen N; Peng D; Xiong X; Liu G; Nie G; Wang Y; Xu J; Wang S; Yang S; Tian Y; Li B; Lu J; Cheng N
Signal Transduct Target Ther; 2024 May; 9(1):107. PubMed ID: 38697972
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome.
Subimerb C; Wongkham C; Khuntikeo N; Leelayuwat C; McGrath MS; Wongkham S
Asian Pac J Cancer Prev; 2014; 15(10):4217-24. PubMed ID: 24935374
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
18. The Role of Circulating Tumor DNA in Renal Cell Carcinoma.
Bergerot PG; Hahn AW; Bergerot CD; Jones J; Pal SK
Curr Treat Options Oncol; 2018 Feb; 19(2):10. PubMed ID: 29464405
[TBL] [Abstract][Full Text] [Related]
19. Genotyping of Circulating Tumor DNA Reveals the Clinically Actionable Mutation Landscape of Advanced Colorectal Cancer.
Cao W; Xu Y; Chang L; Gong Y; Li L; Mo X; Zhang X; Lin G; Zhou J; Liu D; Yi Y; Dai P; Zhu C; Liu T; Chu Y; Guan Y; Chen Y; Wang J; Xia X; Yang L; Yi X; Cheng Y
Mol Cancer Ther; 2019 Jun; 18(6):1158-1167. PubMed ID: 31015309
[TBL] [Abstract][Full Text] [Related]
20. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
